Fallopian tube precursors of ovarian low- and high-grade serous neoplasms

被引:200
|
作者
Vang, Russell [1 ,2 ]
Shih, Ie-Ming [1 ,2 ,3 ]
Kurman, Robert J. [1 ,2 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Gynecol Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
关键词
fallopian tube; high-grade serous carcinoma; ovary; serous borderline tumour; serous tubal intra-epithelial carcinoma; MULLERIAN INCLUSION CYSTS; K-RAS MUTATIONS; INTRAEPITHELIAL CARCINOMA; BORDERLINE TUMORS; CANDIDATE PRECURSOR; INDEPENDENT ORIGIN; GENE-EXPRESSION; TP53; MUTATIONS; CANCER; WOMEN;
D O I
10.1111/his.12046
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vang R, Shih I-M & Kurman R J (2013) Histopathology 62, 44-58 Fallopian tube precursors of ovarian low-and high-grade serous neoplasms Traditionally, it was thought that ovarian high-grade serous carcinoma arises from the ovarian surface epithelium and epithelial inclusion glands and that the pathogenesis is de novo; nonetheless, a convincing precursor in the ovary or peritoneum has not been identified to date. During the last few years, however, there has been a dramatic shift in thinking, and a candidate precursor is now recognized in the fallopian tube, especially within the fimbriated end - serous tubal intra-epithelial carcinoma (STIC). Accordingly, STIC is probably the earliest histologically recognizable lesion in the pathogenesis of high-grade serous carcinoma, but steps in this pathway which precede STIC have also been proposed. With subsequent progression, STIC implants onto the ovary and then develops into an invasive high-grade serous carcinoma with rapid tumour growth. For invasive low-grade serous carcinoma, it is well-established that its pathogenesis begins with serous cystadenoma/adenofibroma, which develops sequentially into atypical proliferative serous tumour (typical serous borderline tumour), non-invasive micropapillary (low-grade) serous carcinoma (micropapillary serous borderline tumour) and then invasive low-grade serous carcinoma in a relatively slow stepwise process. It is presumed that cystadenoma/adenofibroma arises from epithelial inclusion glands in the ovary, but recent evidence suggests that epithelial inclusion glands originate in the fallopian tube. Alternatively, it has been proposed that the other early precursors in the low-grade pathway, including serous borderline tumours, non-invasive implants and endosalpingiosis, may also arise directly from tubal mucosa. Therefore, the precursor of most ovarian high-grade serous carcinomas originates in the fallopian tube, and that for low-grade serous tumours may also be derived from the tube. This review paper provides an overview of the fallopian tube's potential role in the pathogenesis of both types of serous neoplasms of the ovary.
引用
收藏
页码:44 / 58
页数:15
相关论文
共 50 条
  • [21] Cytology of the fallopian tube: A screening model for high-grade serous carcinoma
    Dhanani, Maya
    Nassar, Aziza
    Charles, Melissa S.
    Tri Dinh
    [J]. CYTOJOURNAL, 2018, 15
  • [22] DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer
    Klinkebiel, David
    Zhang, Wa
    Akers, Stacey N.
    Odunsi, Kunle
    Karpf, Adam R.
    [J]. MOLECULAR CANCER RESEARCH, 2016, 14 (09) : 787 - 794
  • [23] Chlamydia trachomatis infection in primary fallopian tube and high-grade serous ovarian cancers: a pilot study
    Laban, Mohamed
    Ibrahim, Eman A.
    Hassanin, Alaa S.
    Nasreldin, Magda A.
    Mansours, Amal
    Khalaf, Waleed M.
    Eldin, Ahmed M. Bahaa
    Hussain, Sherif H.
    Elsafty, Mohammed S.
    Hasanien, Ahmad S.
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2019, 11 : 199 - 205
  • [24] Early Genetic Divergence of High-grade Serous Carcinomas Originating from Low-grade Serous Ovarian Neoplasms
    Chui, M. Herman
    Song, Qianqian
    Wang, Brant
    Wang, Tian-Li
    Vang, Russell S.
    Shih, Le-Ming
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S868 - S870
  • [25] Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer
    Chay, Wen Yee
    McCluggage, W. Glenn
    Lee, Cheng-Han
    Koebel, Martin
    Irving, Julie
    Millar, Joanne
    Gilks, C. Blake
    Tinker, Anna V.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (03) : 431 - 436
  • [26] The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas
    Salvador, Shannon
    Gilks, Blake
    Koebel, Martin
    Huntsman, David
    Rosen, Barry
    Miller, Dianne
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (01) : 58 - 64
  • [27] Fallopian tube single cell analysis reveals myeloid cell alterations in high-grade serous ovarian cancer
    Brand, Joshua
    Haro, Marcela
    Lin, Xianzhi
    Mcgregor, Stephanie M.
    Lawrenson, Kate
    Dinh, Huy Q.
    [J]. ISCIENCE, 2024, 27 (03)
  • [28] Successful reconstitution of high-grade serous ovarian carcinoma in vivo from primary fallopian tube epithelial cells
    Nakamura, Kohei
    Nakayama, Kentaro
    Kiyono, Tohru
    Sanuki, Kaori
    Yamashita, Hitomi
    Ishikawa, Masako
    Kyo, Satoru
    [J]. CANCER SCIENCE, 2018, 109 : 309 - 309
  • [29] In vitro reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cells
    Nakamura, Kohei
    Nakayama, Kentaro
    Kiyono, Tohru
    Ishikawa, Noriyoshi
    Minamoto, Toshiko
    Ishibashi, Tomoka
    Sanuki, Kaori
    Yamashita, Hitomi
    Ono, Ruriko
    Iida, Kouji
    Sasamori, Hiroki
    Sultana, Razia
    Hossain, Mohammad Mahmud
    Ishikawa, Masako
    Kyo, Satoru
    [J]. CANCER RESEARCH, 2017, 77
  • [30] Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer
    Bergsten, Tova M.
    Levy, Sarah E.
    Zink, Katherine E.
    Lusk, Hannah J.
    Pergande, Melissa R.
    Cologna, Stephanie M.
    Burdette, Joanna E.
    Sanchez, Laura M.
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10